146 related articles for article (PubMed ID: 25178451)
1. Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.
Giuliano S; Guastalegname M; Jenco M; Morelli A; Falcone M; Venditti M
BMC Infect Dis; 2014 Sep; 14():475. PubMed ID: 25178451
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Falcone M; Russo A; Iraci F; Carfagna P; Goldoni P; Vullo V; Venditti M
Antimicrob Agents Chemother; 2016 Jan; 60(1):252-7. PubMed ID: 26482315
[TBL] [Abstract][Full Text] [Related]
6. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
Li J; Ren J; Wang W; Wang G; Gu G; Wu X; Wang Y; Huang M; Li J
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):679-689. PubMed ID: 29238932
[TBL] [Abstract][Full Text] [Related]
8. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
9. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.
Freire MP; Pierrotti LC; Filho HH; Ibrahim KY; Magri AS; Bonazzi PR; Hajar L; Diz MP; Pereira J; Hoff PM; Abdala E
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):277-86. PubMed ID: 25169967
[TBL] [Abstract][Full Text] [Related]
10. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections.
Ramos-Castañeda JA; Ruano-Ravina A; Barbosa-Lorenzo R; Paillier-Gonzalez JE; Saldaña-Campos JC; Salinas DF; Lemos-Luengas EV
J Infect; 2018 May; 76(5):438-448. PubMed ID: 29477802
[TBL] [Abstract][Full Text] [Related]
11. Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?
Ulrich RJ; Santhosh K; Mogle JA; Young VB; Rao K
Anaerobe; 2017 Dec; 48():27-33. PubMed ID: 28669864
[TBL] [Abstract][Full Text] [Related]
12. A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult.
Heslop OD; Roye-Green K; Coard K; Mulvey MR
BMC Infect Dis; 2013 Jul; 13():299. PubMed ID: 23815405
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
Marra AR; Wey SB; Castelo A; Gales AC; Cal RG; Filho JR; Edmond MB; Pereira CA
BMC Infect Dis; 2006 Feb; 6():24. PubMed ID: 16478537
[TBL] [Abstract][Full Text] [Related]
15. Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.
Brescini L; Morroni G; Valeriani C; Castelletti S; Mingoia M; Simoni S; Masucci A; Montalti R; Vivarelli M; Giacometti A; Barchiesi F
BMC Infect Dis; 2019 Jul; 19(1):611. PubMed ID: 31299943
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
[TBL] [Abstract][Full Text] [Related]
17. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
[TBL] [Abstract][Full Text] [Related]
18. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.
Louie TJ; Cannon K; Byrne B; Emery J; Ward L; Eyben M; Krulicki W
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S132-42. PubMed ID: 22752862
[TBL] [Abstract][Full Text] [Related]
19. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
[TBL] [Abstract][Full Text] [Related]
20. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
